| Literature DB >> 31520674 |
Vanessa M Lima1, Caroline A Lino1, Nathalia Senger1, Tábatha de Oliveira Silva1, Renata I B Fonseca1, Michael Bader2, Robson A S Santos3, Jose Donato Júnior4, Maria Luiza M Barreto-Chaves1, Gabriela P Diniz5.
Abstract
Obesity is the major risk factor for several cardiovascular and metabolic disorders. Previous studies reported that deletion of Angiotensin II type 2 receptor (AT2R) protects against metabolic dysfunctions induced by high fat (HF) diet. However, the role of AT2R in obesity-induced cardiac hypertrophy remains unclear. Male AT2R knockout (AT2RKO) and wild type (AT2RWT) mice were fed with control or HF diet for 10 weeks. HF diet increased cardiac expression of AT2R in obese mice. Deletion of AT2R did not affect body weight gain, glucose intolerance and fat mass gain induced by HF feeding. However, loss of AT2R prevented HF diet-induced hypercholesterolemia and cardiac remodeling. Mechanistically, we found that pharmacological inhibition or knockdown of AT2R prevented leptin-induced cardiomyocyte hypertrophy in vitro. Collectively, our results suggest that AT2R is involved in obesity-induced cardiac hypertrophy.Entities:
Keywords: Angiotensin II type 2 receptor; Cardiomyocyte hypertrophy; High fat diet; Obesity
Mesh:
Substances:
Year: 2019 PMID: 31520674 DOI: 10.1016/j.mce.2019.110576
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102